TransCure bioServices Webinar Series 2022: Immuno-Oncology Disease Models

TransCure bioServices Webinar Series 2022:

Immuno-Oncology Disease Models

Hosted by TransCure Bioservices’ Sebastien Tabruyn, PhD, CSO.

Accelerating preclinical drug candidate selection using our advanced fully humanized immune system mouse models. In this webinar you will learn more about:

• Our predictive, fully humanized immune system mouse models
• Selecting the most suitable cancer cell lines and/or PDX
• The transient human cytokines boosting process
• Several case studies are presented in detail
• Q&A session with Dr. Tabruyn

Dr. Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Dr. Tabruyn has published 35 peer-reviewed publications in the fields of Oncology, Angiogenesis, Inflammation and Immunity.

Access the full webinar: